Collegium Pharmaceutical Inc (COLL)
30.89
+0.89
(+2.97%)
USD |
NASDAQ |
Nov 21, 11:43
Collegium Pharmaceutical Price: 30.89 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 29.76 | 30.03 | 29.42 | 30.00 | 379121.0 |
| Nov 19, 2024 | 29.06 | 29.91 | 29.06 | 29.75 | 615126.0 |
| Nov 18, 2024 | 29.60 | 29.78 | 28.97 | 29.22 | 562031.0 |
| Nov 15, 2024 | 30.56 | 30.65 | 29.17 | 29.58 | 605403.0 |
| Nov 14, 2024 | 30.48 | 31.53 | 30.03 | 30.27 | 489701.0 |
| Nov 13, 2024 | 31.70 | 31.70 | 29.69 | 30.18 | 728424.0 |
| Nov 12, 2024 | 32.18 | 32.18 | 30.72 | 31.41 | 724017.0 |
| Nov 11, 2024 | 32.51 | 34.04 | 31.85 | 32.18 | 698015.0 |
| Nov 08, 2024 | 33.02 | 34.11 | 31.77 | 32.16 | 1.019M |
| Nov 07, 2024 | 34.62 | 35.62 | 34.34 | 34.71 | 412494.0 |
| Nov 06, 2024 | 35.56 | 35.57 | 34.07 | 34.50 | 331354.0 |
| Nov 05, 2024 | 32.60 | 33.53 | 32.52 | 33.42 | 347694.0 |
| Nov 04, 2024 | 33.44 | 33.82 | 32.63 | 32.72 | 419576.0 |
| Nov 01, 2024 | 34.31 | 34.54 | 33.34 | 33.46 | 452372.0 |
| Oct 31, 2024 | 34.39 | 34.64 | 33.86 | 34.14 | 181486.0 |
| Oct 30, 2024 | 35.02 | 35.62 | 34.63 | 34.67 | 180746.0 |
| Oct 29, 2024 | 34.81 | 35.52 | 34.67 | 35.24 | 311848.0 |
| Oct 28, 2024 | 35.01 | 35.95 | 35.01 | 35.13 | 286877.0 |
| Oct 25, 2024 | 34.47 | 35.02 | 34.33 | 34.70 | 297714.0 |
| Oct 24, 2024 | 35.89 | 36.56 | 34.15 | 34.31 | 286544.0 |
| Oct 23, 2024 | 36.07 | 36.30 | 35.25 | 35.89 | 234716.0 |
| Oct 22, 2024 | 36.45 | 37.40 | 36.10 | 36.19 | 325685.0 |
| Oct 21, 2024 | 38.48 | 38.52 | 35.94 | 36.46 | 469205.0 |
| Oct 18, 2024 | 38.99 | 39.04 | 38.19 | 38.44 | 166913.0 |
| Oct 17, 2024 | 39.62 | 39.82 | 38.65 | 38.93 | 268380.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.89
Minimum
Mar 18 2020
41.86
Maximum
Oct 04 2024
23.53
Average
21.95
Median
Jul 25 2023
Price Benchmarks
| Pfizer Inc | 24.92 |
| Context Therapeutics Inc | 1.535 |
| NovaBay Pharmaceuticals Inc | 0.7026 |
| Palatin Technologies Inc | 0.9142 |
| iBio Inc | 2.28 |
Price Related Metrics
| PE Ratio | 13.26 |
| PS Ratio | 2.367 |
| PEG Ratio | 0.0092 |
| Price to Book Value | 4.252 |
| Price to Free Cash Flow | 7.372 |
| Earnings Yield | 7.54% |
| Market Cap | 996.21M |
| PEGY Ratio | 0.0092 |
| Operating PE Ratio | 7.332 |
| Normalized PE Ratio | 12.30 |